Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma

Clinical trial NCT00092274 · WITHDRAWN

Trial details

NCT number: NCT00092274
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Follicular

Start date: 2004-09-01
Primary completion: 2005-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.